two new light-activated drugs

May 2000

There's lots of excitement about two new light-activated drugs. They are coming to the market now in the U.S...and a little later in Canada.

Physicians provide these new phototherapies in their office.

Visudyne (verteporfin, CibaVision/QLT PhotoTherapeutics) is for the WET form of macular degeneration. The "wet" form is less common than the "dry" form...but it's more severe.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote